{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:14:16Z","timestamp":1793294056551,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A vaccine based on outer membrane vesicles of pertussis (omvPV) is protective in a mouse-challenge model and induces a broad antibody and mixed Th1\/Th2\/Th17 response against multiple antigens following subcutaneous immunization. However, this route did not result in mucosal immunity and did not prevent nasopharyngeal colonization. In this study, we explored the potential of intranasal immunization with omvPV. Only intranasal immunization induced strong mucosal immune responses that encompasses enhanced pulmonary and nasal IgA antibody levels, mainly directed against Vag8 and LPS. Furthermore, high numbers of IgA- and IgG-producing plasma cells were detected as well as lung-resident IgA memory B-cells. Finally, only intranasal immunization induced pulmonary Th1\/Th17-related cytokine responses. The magnitude and type of systemic immunity was comparable between both routes and included high systemic IgG antibody levels, strong IgG-producing plasma cell responses, memory B-cells residing in the spleen and systemic Th1\/Th2\/Th17-related cytokine responses. Importantly, only intranasal immunization prevented colonization in both the lungs and the nasal cavity. In conclusion, intranasal omvPV immunization induces mucosal IgA and Th17-mediated responses without influencing the systemic immunity profile. These responses resulted in prevention of <jats:italic>Bordetella pertussis<\/jats:italic> colonization in the respiratory tract, including the nasal cavity, thereby potentially preventing transmission.<\/jats:p>","DOI":"10.1038\/s41598-020-63998-2","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T10:02:59Z","timestamp":1588240979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Intranasal immunization with outer membrane vesicle pertussis vaccine confers broad protection through mucosal IgA and Th17 responses"],"prefix":"10.1038","volume":"10","author":[{"given":"Ren\u00e9 H. M.","family":"Raeven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dedeke","family":"Rockx-Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Kanojia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"van der Maas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim H. E.","family":"Bindels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rimko","family":"ten Have","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elly","family":"van Riet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Metz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon F. A.","family":"Kersten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,30]]},"reference":[{"key":"63998_CR1","unstructured":"Pertussis vaccines: WHO position paper. Releve epidemiologique hebdomadaire \/ Section d\u2019hygiene du Secretariat de la Societe des Nations = Weekly epidemiological record \/ Health Section of the Secretariat of the League of Nations 85, 385\u2013400 (2010)."},{"key":"63998_CR2","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1586\/erv.12.118","volume":"11","author":"R Libster","year":"2012","unstructured":"Libster, R. & Edwards, K. M. Re-emergence of pertussis: what are the solutions? Expert review of vaccines 11, 1331\u20131346, https:\/\/doi.org\/10.1586\/erv.12.118 (2012).","journal-title":"Expert review of vaccines"},{"key":"63998_CR3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1080\/14760584.2018.1445530","volume":"17","author":"F Martinon-Torres","year":"2018","unstructured":"Martinon-Torres, F., Heininger, U., Thomson, A. & Wirsing von Konig, C. H. Controlling pertussis: how can we do it? A focus on immunization. Expert review of vaccines 17, 289\u2013297, https:\/\/doi.org\/10.1080\/14760584.2018.1445530 (2018).","journal-title":"Expert review of vaccines"},{"key":"63998_CR4","doi-asserted-by":"publisher","unstructured":"Burdin, N., Handy, L. K. & Plotkin, S. A. What Is Wrong with Pertussis Vaccine Immunity? The Problem of Waning Effectiveness of Pertussis Vaccines. Cold Spring Harb Perspect Biol 9, https:\/\/doi.org\/10.1101\/cshperspect.a029454 (2017).","DOI":"10.1101\/cshperspect.a029454"},{"key":"63998_CR5","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1073\/pnas.1314688110","volume":"111","author":"JM Warfel","year":"2014","unstructured":"Warfel, J. M., Zimmerman, L. I. & Merkel, T. J. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proceedings of the National Academy of Sciences of the United States of America 111, 787\u2013792, https:\/\/doi.org\/10.1073\/pnas.1314688110 (2014).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"63998_CR6","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.12688\/f1000research.11654.1","volume":"6","author":"C Gill","year":"2017","unstructured":"Gill, C., Rohani, P. & Thea, D. M. The relationship between mucosal immunity, nasopharyngeal carriage, asymptomatic transmission and the resurgence of Bordetella pertussis. F1000Res 6, 1568, https:\/\/doi.org\/10.12688\/f1000research.11654.1 (2017).","journal-title":"F1000Res"},{"key":"63998_CR7","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.3389\/fimmu.2018.03068","volume":"9","author":"L Solans","year":"2018","unstructured":"Solans, L. & Locht, C. The Role of Mucosal Immunity in Pertussis. Frontiers in immunology 9, 3068, https:\/\/doi.org\/10.3389\/fimmu.2018.03068 (2018).","journal-title":"Frontiers in immunology"},{"key":"63998_CR8","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/mi.2012.117","volume":"6","author":"JM Warfel","year":"2013","unstructured":"Warfel, J. M. & Merkel, T. J. Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates. Mucosal immunology 6, 787\u2013796, https:\/\/doi.org\/10.1038\/mi.2012.117 (2013).","journal-title":"Mucosal immunology"},{"key":"63998_CR9","doi-asserted-by":"publisher","first-page":"e104548","DOI":"10.1371\/journal.pone.0104548","volume":"9","author":"RHM Raeven","year":"2014","unstructured":"Raeven, R. H. M. et al. Molecular Signatures of the Evolving Immune Response in Mice following a Bordetella pertussis Infection. PloS one 9, e104548, https:\/\/doi.org\/10.1371\/journal.pone.0104548 (2014).","journal-title":"PloS one"},{"key":"63998_CR10","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1038\/s41385-018-0073-9","volume":"11","author":"L Solans","year":"2018","unstructured":"Solans, L. et al. IL-17-dependent SIgA-mediated protection against nasal Bordetella pertussis infection by live attenuated BPZE1. vaccine. Mucosal immunology 11, 1753\u20131762, https:\/\/doi.org\/10.1038\/s41385-018-0073-9 (2018).","journal-title":"vaccine. Mucosal immunology"},{"key":"63998_CR11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/14760584.2017.1276832","volume":"16","author":"DF Hozbor","year":"2017","unstructured":"Hozbor, D. F. Outer membrane vesicles: an attractive candidate for pertussis vaccines. Expert review of vaccines 16, 193\u2013196, https:\/\/doi.org\/10.1080\/14760584.2017.1276832 (2017).","journal-title":"Expert review of vaccines"},{"key":"63998_CR12","doi-asserted-by":"publisher","first-page":"4639","DOI":"10.1016\/j.vaccine.2008.07.004","volume":"26","author":"R Roberts","year":"2008","unstructured":"Roberts, R. et al. Outer membrane vesicles as acellular vaccine against pertussis. Vaccine 26, 4639\u20134646, https:\/\/doi.org\/10.1016\/j.vaccine.2008.07.004 (2008).","journal-title":"Vaccine"},{"key":"63998_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/srep38240","volume":"6","author":"RHM Raeven","year":"2016","unstructured":"Raeven, R. H. M. et al. Bordetella pertussis outer membrane vesicle vaccine confers equal efficacy in mice with milder inflammatory responses compared to a whole-cell vaccine. Sci Rep 6, 38240, https:\/\/doi.org\/10.1038\/srep38240 (2016).","journal-title":"Sci Rep"},{"key":"63998_CR14","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1016\/j.vaccine.2016.04.079","volume":"34","author":"D Bottero","year":"2016","unstructured":"Bottero, D. et al. Characterization of the immune response induced by pertussis OMVs-based vaccine. Vaccine 34, 3303\u20133309, https:\/\/doi.org\/10.1016\/j.vaccine.2016.04.079 (2016).","journal-title":"Vaccine"},{"key":"63998_CR15","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/mi.2017.81","volume":"11","author":"RHM Raeven","year":"2018","unstructured":"Raeven, R. H. M. et al. Molecular and cellular signatures underlying superior immunity against Bordetella pertussis upon pulmonary vaccination. Mucosal immunology 11, 979\u2013993, https:\/\/doi.org\/10.1038\/mi.2017.81 (2018).","journal-title":"Mucosal immunology"},{"key":"63998_CR16","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1021\/acs.jproteome.5b00258","volume":"14","author":"RHM Raeven","year":"2015","unstructured":"Raeven, R. H. M. et al. Immunoproteomic Profiling of Bordetella pertussis Outer Membrane Vesicle Vaccine Reveals Broad and Balanced Humoral Immunogenicity. Journal of proteome research 14, 2929\u20132942, https:\/\/doi.org\/10.1021\/acs.jproteome.5b00258 (2015).","journal-title":"Journal of proteome research"},{"key":"63998_CR17","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.1073\/pnas.1100782108","volume":"108","author":"J Kubler-Kielb","year":"2011","unstructured":"Kubler-Kielb, J. et al. Oligosaccharide conjugates of Bordetella pertussis and bronchiseptica induce bactericidal antibodies, an addition to pertussis vaccine. Proceedings of the National Academy of Sciences of the United States of America 108, 4087\u20134092, https:\/\/doi.org\/10.1073\/pnas.1100782108 (2011).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"63998_CR18","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/1348-0421.12504","volume":"61","author":"K Suzuki","year":"2017","unstructured":"Suzuki, K. et al. Protective effects of in vivo-expressed autotransporters against Bordetella pertussis infection. Microbiol Immunol 61, 371\u2013379, https:\/\/doi.org\/10.1111\/1348-0421.12504 (2017).","journal-title":"Microbiol Immunol"},{"key":"63998_CR19","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1128\/IAI.67.3.1424-1431.1999","volume":"67","author":"AA Weiss","year":"1999","unstructured":"Weiss, A. A., Mobberley, P. S., Fernandez, R. C. & Mink, C. M. Characterization of human bactericidal antibodies to Bordetella pertussis. Infection and immunity 67, 1424\u20131431 (1999).","journal-title":"Infection and immunity"},{"key":"63998_CR20","doi-asserted-by":"publisher","first-page":"4306","DOI":"10.1016\/j.vaccine.2008.06.017","volume":"26","author":"N Marr","year":"2008","unstructured":"Marr, N. et al. Protective activity of the Bordetella pertussis BrkA autotransporter in the murine lung colonization model. Vaccine 26, 4306\u20134311, https:\/\/doi.org\/10.1016\/j.vaccine.2008.06.017 (2008).","journal-title":"Vaccine"},{"key":"63998_CR21","doi-asserted-by":"publisher","unstructured":"Kanojia, G. et al. Development of a thermostable spray dried outer membrane vesicle pertussis vaccine for pulmonary immunization. J Control Release\u00a0286,\u00a0167\u2013178,\u00a0https:\/\/doi.org\/10.1016\/j.jconrel.2018.07.035 (2018).","DOI":"10.1016\/j.jconrel.2018.07.035"},{"key":"63998_CR22","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3109\/1061186X.2010.523790","volume":"18","author":"I Jabbal-Gill","year":"2010","unstructured":"Jabbal-Gill, I. Nasal vaccine innovation. J. Drug Target. 18, 771\u2013786, https:\/\/doi.org\/10.3109\/1061186X.2010.523790 (2010).","journal-title":"J. Drug Target."},{"key":"63998_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0168-1656(99)00155-8","volume":"75","author":"M Thalen","year":"1999","unstructured":"Thalen, M. et al. Rational medium design for Bordetella pertussis: basic metabolism. Journal of biotechnology 75, 147\u2013159 (1999).","journal-title":"Journal of biotechnology"},{"key":"63998_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jim.2003.12.015","volume":"286","author":"S Crotty","year":"2004","unstructured":"Crotty, S., Aubert, R. D., Glidewell, J. & Ahmed, R. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J. Immunol Methods. 286, 111\u2013122, https:\/\/doi.org\/10.1016\/j.jim.2003.12.015 (2004).","journal-title":"J. Immunol Methods."},{"key":"63998_CR25","doi-asserted-by":"publisher","first-page":"ftv067","DOI":"10.1093\/femspd\/ftv067","volume":"73","author":"J Brummelman","year":"2015","unstructured":"Brummelman, J., Wilk, M. M., Han, W. G., van Els, C. A. & Mills, K. H. Roads to the development of improved pertussis vaccines paved by immunology. Pathogens and disease 73, ftv067, https:\/\/doi.org\/10.1093\/femspd\/ftv067 (2015).","journal-title":"Pathogens and disease"},{"key":"63998_CR26","doi-asserted-by":"publisher","first-page":"626","DOI":"10.3201\/eid2004.131478","volume":"20","author":"C Lam","year":"2014","unstructured":"Lam, C. et al. Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia. Emerging infectious diseases 20, 626\u2013633, https:\/\/doi.org\/10.3201\/eid2004.131478 (2014).","journal-title":"Emerging infectious diseases"},{"key":"63998_CR27","doi-asserted-by":"publisher","unstructured":"Etskovitz, H., Anastasio, N., Green, E. & May, M. Role of Evolutionary Selection Acting on Vaccine Antigens in the Re-Emergence of Bordetella Pertussis. Diseases 7, https:\/\/doi.org\/10.3390\/diseases7020035 (2019).","DOI":"10.3390\/diseases7020035"},{"key":"63998_CR28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0264-410X(01)00269-9","volume":"20","author":"DC Oliver","year":"2001","unstructured":"Oliver, D. C. & Fernandez, R. C. Antibodies to BrkA augment killing of Bordetella pertussis. Vaccine 20, 235\u2013241 (2001).","journal-title":"Vaccine"},{"key":"63998_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-30558-8","volume":"8","author":"ES Hovingh","year":"2018","unstructured":"Hovingh, E. S. et al. Detection of opsonizing antibodies directed against a recently circulating Bordetella pertussis strain in paired plasma samples from symptomatic and recovered pertussis patients. Sci. Rep. 8, 12039, https:\/\/doi.org\/10.1038\/s41598-018-30558-8 (2018).","journal-title":"Sci. Rep."},{"key":"63998_CR30","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.3389\/fimmu.2019.01364","volume":"10","author":"RHM Raeven","year":"2019","unstructured":"Raeven, R. H. M. et al. Antibody Specificity Following a Recent Bordetella pertussis Infection in Adolescence Is Correlated With the Pertussis Vaccine Received in Childhood. Frontiers in immunology 10, 1364, https:\/\/doi.org\/10.3389\/fimmu.2019.01364 (2019).","journal-title":"Frontiers in immunology"},{"key":"63998_CR31","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1128\/JCM.20.2.167-170.1984","volume":"20","author":"EI Tuomanen","year":"1984","unstructured":"Tuomanen, E. I., Zapiain, L. A., Galvan, P. & Hewlett, E. L. Characterization of antibody inhibiting adherence of Bordetella pertussis to human respiratory epithelial cells. Journal of clinical microbiology 20, 167\u2013170 (1984).","journal-title":"Journal of clinical microbiology"},{"key":"63998_CR32","doi-asserted-by":"publisher","unstructured":"Geurtsen, J., Fae, K. C. & van den Dobbelsteen, G. P. Importance of (antibody-dependent) complement-mediated serum killing in protection against Bordetella pertussis. Expert review of vaccines 10, 1229\u201340, https:\/\/doi.org\/10.1586\/14760584.2014.944901 (2014).","DOI":"10.1586\/14760584.2014.944901"},{"key":"63998_CR33","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1038\/nm1213","volume":"11","author":"J Holmgren","year":"2005","unstructured":"Holmgren, J. & Czerkinsky, C. Mucosal immunity and vaccines. Nature medicine 11, S45\u201353, https:\/\/doi.org\/10.1038\/nm1213 (2005).","journal-title":"Nature medicine"},{"key":"63998_CR34","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nri.2015.3","volume":"16","author":"SN Mueller","year":"2016","unstructured":"Mueller, S. N. & Mackay, L. K. Tissue-resident memory T cells: local specialists in immune defence. Nature reviews. Immunology 16, 79\u201389, https:\/\/doi.org\/10.1038\/nri.2015.3 (2016).","journal-title":"Nature reviews. Immunology"},{"key":"63998_CR35","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/ni.3056","volume":"16","author":"C Chiu","year":"2015","unstructured":"Chiu, C. & Openshaw, P. J. Antiviral B cell and T cell immunity in the lungs. Nature immunology 16, 18\u201326, https:\/\/doi.org\/10.1038\/ni.3056 (2015).","journal-title":"Nature immunology"},{"key":"63998_CR36","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nm.3883","volume":"21","author":"CO Park","year":"2015","unstructured":"Park, C. O. & Kupper, T. S. The emerging role of resident memory T cells in protective immunity and inflammatory disease. Nature medicine 21, 688\u2013697, https:\/\/doi.org\/10.1038\/nm.3883 (2015).","journal-title":"Nature medicine"},{"key":"63998_CR37","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1371\/journal.ppat.0020065","volume":"2","author":"N Mielcarek","year":"2006","unstructured":"Mielcarek, N. et al. Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough. Plos pathogens 2, e65, https:\/\/doi.org\/10.1371\/journal.ppat.0020065 (2006).","journal-title":"Plos pathogens"},{"key":"63998_CR38","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.imlet.2018.03.012","volume":"198","author":"W Shi","year":"2018","unstructured":"Shi, W. et al. Novel intranasal pertussis vaccine based on bacterium-like particles as a mucosal adjuvant. Immunol Lett 198, 26\u201332, https:\/\/doi.org\/10.1016\/j.imlet.2018.03.012 (2018).","journal-title":"Immunol Lett"},{"key":"63998_CR39","doi-asserted-by":"publisher","first-page":"325","DOI":"10.4161\/hv.22755","volume":"9","author":"C Asokanathan","year":"2013","unstructured":"Asokanathan, C., Corbel, M. & Xing, D. A CpG-containing oligodeoxynucleotide adjuvant for acellular pertussis vaccine improves the protective response against Bordetella pertussis. Human vaccines & immunotherapeutics 9, 325\u2013331 (2013).","journal-title":"Human vaccines & immunotherapeutics"},{"key":"63998_CR40","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1038\/s41385-018-0080-x","volume":"11","author":"AC Allen","year":"2018","unstructured":"Allen, A. C. et al. Sustained protective immunity against Bordetella pertussis nasal colonization by intranasal immunization with a vaccine-adjuvant combination that induces IL-17-secreting TRM. cells. Mucosal immunology 11, 1763\u20131776, https:\/\/doi.org\/10.1038\/s41385-018-0080-x (2018).","journal-title":"cells. Mucosal immunology"},{"key":"63998_CR41","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/S0264-410X(02)00516-9","volume":"21","author":"M Isaka","year":"2003","unstructured":"Isaka, M. et al. Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant. Vaccine 21, 1165\u20131173 (2003).","journal-title":"Vaccine"},{"key":"63998_CR42","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/j.vaccine.2010.12.068","volume":"29","author":"CJ Asensio","year":"2011","unstructured":"Asensio, C. J. et al. Outer membrane vesicles obtained from Bordetella pertussis Tohama expressing the lipid A deacylase PagL as a novel acellular vaccine candidate. Vaccine 29, 1649\u20131656, https:\/\/doi.org\/10.1016\/j.vaccine.2010.12.068 (2011).","journal-title":"Vaccine"},{"key":"63998_CR43","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41590-018-0260-6","volume":"20","author":"SR Allie","year":"2019","unstructured":"Allie, S. R. et al. The establishment of resident memory B cells in the lung requires local antigen encounter. Nature immunology 20, 97\u2013108, https:\/\/doi.org\/10.1038\/s41590-018-0260-6 (2019).","journal-title":"Nature immunology"},{"key":"63998_CR44","doi-asserted-by":"publisher","first-page":"4846","DOI":"10.1128\/IAI.69.8.4846-4850.2001","volume":"69","author":"SM Hellwig","year":"2001","unstructured":"Hellwig, S. M., van Spriel, A. B., Schellekens, J. F., Mooi, F. R. & van de Winkel, J. G. Immunoglobulin A-mediated protection against Bordetella pertussis infection. Infection and immunity 69, 4846\u20134850, https:\/\/doi.org\/10.1128\/IAI.69.8.4846-4850.2001 (2001).","journal-title":"Infection and immunity"},{"key":"63998_CR45","doi-asserted-by":"publisher","first-page":"e1003264","DOI":"10.1371\/journal.ppat.1003264","volume":"9","author":"PJ Ross","year":"2013","unstructured":"Ross, P. J. et al. Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine. Plos pathogens 9, e1003264, https:\/\/doi.org\/10.1371\/journal.ppat.1003264 (2013).","journal-title":"Plos pathogens"},{"key":"63998_CR46","doi-asserted-by":"publisher","first-page":"e0164027","DOI":"10.1371\/journal.pone.0164027","volume":"11","author":"RHM Raeven","year":"2016","unstructured":"Raeven, R. H. M. et al. Immunological Signatures after Bordetella pertussis Infection Demonstrate Importance of Pulmonary Innate Immune Cells. Plos one 11, e0164027, https:\/\/doi.org\/10.1371\/journal.pone.0164027 (2016).","journal-title":"Plos one"},{"key":"63998_CR47","doi-asserted-by":"publisher","first-page":"233","DOI":"10.4049\/jimmunol.1602051","volume":"199","author":"MM Wilk","year":"2017","unstructured":"Wilk, M. M. et al. Lung CD4 Tissue-Resident Memory T Cells Mediate Adaptive Immunity Induced by Previous Infection of Mice with Bordetella pertussis. J. Immunol. 199, 233\u2013243, https:\/\/doi.org\/10.4049\/jimmunol.1602051 (2017).","journal-title":"J. Immunol."},{"key":"63998_CR48","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1586\/14760584.2015.1026808","volume":"14","author":"A Zariri","year":"2015","unstructured":"Zariri, A. & van der Ley, P. Biosynthetically engineered lipopolysaccharide as vaccine adjuvant. Expert review of vaccines 14, 861\u2013876, https:\/\/doi.org\/10.1586\/14760584.2015.1026808 (2015).","journal-title":"Expert review of vaccines"},{"key":"63998_CR49","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ebiom.2017.07.013","volume":"22","author":"O Launay","year":"2017","unstructured":"Launay, O. et al. Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe. EBioMedicine 22, 164\u2013172, https:\/\/doi.org\/10.1016\/j.ebiom.2017.07.013 (2017).","journal-title":"EBioMedicine"},{"key":"63998_CR50","doi-asserted-by":"publisher","first-page":"4545","DOI":"10.1128\/IAI.69.7.4545-4553.2001","volume":"69","author":"LF Fries","year":"2001","unstructured":"Fries, L. F. et al. Safety and immunogenicity of a proteosome-Shigella flexneri 2a lipopolysaccharide vaccine administered intranasally to healthy adults. Infection and immunity 69, 4545\u20134553, https:\/\/doi.org\/10.1128\/IAI.69.7.4545-4553.2001 (2001).","journal-title":"Infection and immunity"},{"key":"63998_CR51","doi-asserted-by":"publisher","first-page":"e6999","DOI":"10.1371\/journal.pone.0006999","volume":"4","author":"DJ Lewis","year":"2009","unstructured":"Lewis, D. J. et al. Transient facial nerve paralysis (Bell\u2019s palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin. Plos one 4, e6999, https:\/\/doi.org\/10.1371\/journal.pone.0006999 (2009).","journal-title":"Plos one"},{"key":"63998_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-51356-w","volume":"9","author":"E Valli","year":"2019","unstructured":"Valli, E. et al. LTA1 is a safe, intranasal enterotoxin-based adjuvant that improves vaccine protection against influenza in young, old and B-cell-depleted (muMT) mice. Sci. Rep. 9, 15128, https:\/\/doi.org\/10.1038\/s41598-019-51356-w (2019).","journal-title":"Sci. Rep."},{"key":"63998_CR53","first-page":"729","volume":"71","author":"M Birkhoff","year":"2009","unstructured":"Birkhoff, M., Leitz, M. & Marx, D. Advantages of Intranasal Vaccination and Considerations on Device Selection. Indian Journal of Pharmaceutical Sciences 71, 729\u2013731 (2009).","journal-title":"Indian Journal of Pharmaceutical Sciences"},{"issue":"Suppl 1","key":"63998_CR54","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1093\/infdis\/jit493","volume":"209","author":"TJ Merkel","year":"2014","unstructured":"Merkel, T. J. & Halperin, S. A. Nonhuman primate and human challenge models of pertussis. The Journal of infectious diseases 209(Suppl 1), S20\u201323, https:\/\/doi.org\/10.1093\/infdis\/jit493 (2014).","journal-title":"The Journal of infectious diseases"},{"key":"63998_CR55","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/01.inf.0000258699.64164.6d","volume":"26","author":"AM Wendelboe","year":"2007","unstructured":"Wendelboe, A. M. et al. Transmission of Bordetella pertussis to young infants. The Pediatric infectious disease journal 26, 293\u2013299, https:\/\/doi.org\/10.1097\/01.inf.0000258699.64164.6d (2007).","journal-title":"The Pediatric infectious disease journal"},{"key":"63998_CR56","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.1172\/JCI121309","volume":"128","author":"R da Silva Antunes","year":"2018","unstructured":"da Silva Antunes, R. et al. Th1\/Th17 polarization persists following whole-cell pertussis vaccination despite repeated acellular boosters. The Journal of clinical investigation 128, 3853\u20133865, https:\/\/doi.org\/10.1172\/JCI121309 (2018).","journal-title":"The Journal of clinical investigation"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63998-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63998-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63998-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T09:48:32Z","timestamp":1670320112000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63998-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,30]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["63998"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-63998-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,30]]},"assertion":[{"value":"10 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors were employed by Intravacc that at the time of submission of the manuscript was completely funded by the Dutch Government.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7396"}}